Kolltan Pharmaceuticals
Latest round
- Series D
Last raised
- Mar 2014
Total raised
- $131M
Investors
- 9
About Kolltan Pharmaceuticals
Founded in 2007, Kolltan Pharmaceuticals, Inc. develops monoclonal antibody oncology therapeutics for the treatment of cancer and other diseases.
Who invested in Kolltan Pharmaceuticals
9 investors across 5 rounds
See all investors in Kolltan Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Kolltan Pharmaceuticals
Who invested in Kolltan Pharmaceuticals?
Kolltan Pharmaceuticals has 9 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Kolltan Pharmaceuticals raised?
Kolltan Pharmaceuticals has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did Kolltan Pharmaceuticals last raise money?
Kolltan Pharmaceuticals's most recent round on record is a Series D, in Mar 2014.
What does Kolltan Pharmaceuticals do?
Founded in 2007, Kolltan Pharmaceuticals, Inc.
Where is Kolltan Pharmaceuticals headquartered?
Kolltan Pharmaceuticals is headquartered in New Haven, US.
Which VCs invest in companies like Kolltan Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Kolltan Pharmaceuticals's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series D
Raising like Kolltan Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.